Introduction
Epidemiologic data indicate that sleep disturbance and short sleep duration adversely impact human physical health (Gangwisch et al., 2007) and mortality risk (Dew et al., 2003; Gangwisch et al., 2008; Shankar et al., 2008) . Although the biological basis for these links between sleep and health are not known, risk of a wide spectrum of medical conditions including cardiovascular disease, arthritis, diabetes, certain cancers, obesity, and functional decline is associated with activation of cellular signals that initiate expression of inflammatory cytokines (Karin, 2005; Volpato et al., 2001) .
Sleep loss has been found to have consequences on inflammatory mechanisms. Experimental sleep deprivation induces increases in circulating levels of inflammatory markers such as interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), and C-reactive protein (CRP) (Irwin et al., 2004; Meier-Ewert et al., 2004; Shearer et al., 2001 ). In addition, early night partial sleep deprivation (PSD) activates cellular expression of IL-6 and TNF-a, with effects on up-stream sources of cellular inflammatory cytokine expression (Irwin et al., 2006) . Moreover, such up-regulation of inflammatory gene expression following such sleep loss (Irwin et al., 2006 ) is due to activation of nuclear factor (NF)-jB transcription control pathways (Irwin et al., 2008) that plays a key role in controlling cellular expression of proinflammatory genes (Pascual and Glass, 2006) . Activation of NF-jB following sleep loss, however, occurs primarily in females, but not in males (Irwin et al., 2008) .
There are well-known sex differences in the prevalence of inflammatory disorders, with females being between 2 and 9 times as likely as males to develop autoimmune disorders including arthritis and diabetes (Whitacre, 2001 ). In addition, whereas cardiovascular disease is thought to have an inflammatory basis and is more prevalent in males than females, recent epidemiologic data indicate that subjective symptoms of disturbed sleep and short sleep duration were associated with a greater risk of cardiovascular disease in females than in males, even after control for relevant confounders such as body mass index and physical activity (Cappuccio et al., 2007; Newman et al., 2000) . Moreover, Suarez (Suarez, 2008) recently found that poor sleep quality and self-reported prolonged sleep latency were associated with increases of CRP and IL-6 in females but not males. Hence, in this study we sought to determine sex differences in the effects of experimental sleep loss on the inflammatory response by measuring the production of proinflammatory cytokines by monocytes following ligation of the Toll-like receptor 4 (TLR4) with lipopolysaccharide (LPS). 
